Acadia Healthcare Company, Inc. ACHC
We take great care to ensure that the data presented and summarized in this overview for Acadia Healthcare Company, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ACHC
View all-
Vanguard Group Inc Valley Forge, PA8.86MShares$588 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.52MShares$566 Million0.41% of portfolio
-
Black Rock Inc. New York, NY8.23MShares$546 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA7.92MShares$525 Million0.11% of portfolio
-
Invesco Ltd. Atlanta, GA3.28MShares$218 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.17MShares$210 Million0.07% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.91MShares$193 Million0.62% of portfolio
-
Jpmorgan Chase & CO New York, NY2.85MShares$189 Million0.02% of portfolio
-
State Street Corp Boston, MA2.73MShares$181 Million0.01% of portfolio
-
Viking Global Investors LP2.56MShares$170 Million0.77% of portfolio
Latest Institutional Activity in ACHC
Top Purchases
Top Sells
About ACHC
Acadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Insider Transactions at ACHC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 09
2024
|
Christopher H. Hunter Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,899
-2.01%
|
$125,334
$66.06 P/Share
|
May 09
2024
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
525
-0.45%
|
$34,650
$66.06 P/Share
|
Apr 23
2024
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
552
-0.47%
|
$38,640
$70.26 P/Share
|
Apr 11
2024
|
Christopher H. Hunter Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,485
-1.55%
|
$111,375
$75.8 P/Share
|
Apr 11
2024
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
496
-0.42%
|
$37,200
$75.8 P/Share
|
Mar 24
2024
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,803
-2.32%
|
$213,028
$76.49 P/Share
|
Mar 05
2024
|
Wade D Miquelon |
SELL
Open market or private sale
|
Direct |
2,203
-4.56%
|
$187,255
$85.39 P/Share
|
Mar 04
2024
|
Vicky B Gregg |
SELL
Open market or private sale
|
Direct |
2,500
-8.52%
|
$212,500
$85.56 P/Share
|
Feb 28
2024
|
Heather Brianne Dixon Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,560
+28.36%
|
-
|
Feb 28
2024
|
Brian Farley EVP , GC and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
4,680
+17.11%
|
-
|
Feb 28
2024
|
Christopher H. Hunter Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44,091
+20.95%
|
-
|
Feb 28
2024
|
John S. Hollinsworth EVP of Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
11,495
-8.7%
|
$954,085
$83.43 P/Share
|
Feb 28
2024
|
John S. Hollinsworth EVP of Operations |
BUY
Grant, award, or other acquisition
|
Direct |
47,550
+10.79%
|
-
|
Dec 13
2023
|
Debra K Osteen |
SELL
Open market or private sale
|
Direct |
35,000
-4.92%
|
$2,695,000
$77.67 P/Share
|
Dec 12
2023
|
Debra K Osteen |
SELL
Open market or private sale
|
Direct |
8,000
-1.11%
|
$608,000
$76.23 P/Share
|
Nov 14
2023
|
John S. Hollinsworth EVP of Operations |
SELL
Open market or private sale
|
Direct |
92,500
-13.52%
|
$6,752,500
$73.93 P/Share
|
Nov 10
2023
|
Reeve B Waud |
BUY
Grant, award, or other acquisition
|
Indirect |
68,028
+9.43%
|
$4,966,044
$73.02 P/Share
|
Nov 10
2023
|
John S. Hollinsworth EVP of Operations |
SELL
Open market or private sale
|
Direct |
20,000
-10.15%
|
$1,460,000
$73.0 P/Share
|
Nov 08
2023
|
John S. Hollinsworth EVP of Operations |
SELL
Open market or private sale
|
Direct |
12,500
-5.96%
|
$925,000
$74.5 P/Share
|
Nov 08
2023
|
Debra K Osteen |
SELL
Open market or private sale
|
Direct |
15,000
-2.04%
|
$1,110,000
$74.21 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 264K shares |
---|
Open market or private sale | 188K shares |
---|---|
Payment of exercise price or tax liability | 20.4K shares |